Short Interest in Cemtrex, Inc. (NASDAQ:CETX) Decreases By 99.7%

Cemtrex, Inc. (NASDAQ:CETXGet Free Report) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 4,400 shares, a decline of 99.7% from the October 31st total of 1,330,000 shares. Currently, 0.6% of the company’s shares are short sold. Based on an average trading volume of 196,000 shares, the days-to-cover ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of Cemtrex in a research note on Thursday. They set a “hold” rating for the company.

Get Our Latest Analysis on Cemtrex

Cemtrex Price Performance

NASDAQ:CETX traded up $0.01 during trading hours on Thursday, hitting $3.21. 282,822 shares of the company were exchanged, compared to its average volume of 56,972. The company has a fifty day simple moving average of $12.41 and a 200 day simple moving average of $9.58. Cemtrex has a one year low of $3.00 and a one year high of $13,629.00. The company has a quick ratio of 1.35, a current ratio of 1.89 and a debt-to-equity ratio of 48.20.

About Cemtrex

(Get Free Report)

Cemtrex, Inc operates as a technology company in the United States and internationally. It operates through Security, Industrial Services, and Cemtrex Corporate segments. The company offers browser-based video monitoring and analytics-based recognition systems, cameras, servers, and access control systems for security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices; and provides critical security and video surveillance solutions utilizing artificial intelligence based data algorithms.

Further Reading

Receive News & Ratings for Cemtrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cemtrex and related companies with MarketBeat.com's FREE daily email newsletter.